Neree Payan1, Benoit Presles2, François Brunotte2, Charles Coutant3, Isabelle Desmoulins4, Jean-Marc Vrigneaud2,5, Alexandre Cochet2,5. 1. ImViA EA 7535, University of Burgundy, Dijon, France. nerea.payan@u-bourgogne.fr. 2. ImViA EA 7535, University of Burgundy, Dijon, France. 3. Department of Surgical Oncology, Georges-François Leclerc Cancer Center, Dijon, France. 4. Department of Medical Oncology, Georges-François Leclerc Cancer Center, Dijon, France. 5. Department of Nuclear Medicine, Georges-François Leclerc Cancer Center, Dijon, France.
Abstract
PURPOSE: The aim of this prospective study is to analyze the global tumor blood flow (BF) and its heterogeneity in newly diagnosed breast cancer (BC) according to tumor biological characteristics and molecular subtypes. These perfusion parameters were compared to those classically derived from metabolic studies to investigate links between perfusion and metabolism. METHODS: Two hundred seventeen newly diagnosed BC patients underwent a 18F-FDG PET/CT exam before any treatment. A 2-min dynamic acquisition, centered on the chest, was performed immediately after intravenous injection of 3 MBq/kg of 18F-FDG, followed by a two-step static acquisition 90 min later. Tumor BF was calculated (in ml/min/g) using a single compartment kinetic model. In addition to standard PET parameters, texture features (TF) describing the heterogeneity of tumor perfusion and metabolism were extracted. Patients were divided into three groups: Luminal (HR+/HER2-), HER2 (HER2+), and TN (HR-/HER2-). Global and TF parameters of BF and metabolism were compared in different groups of patients according to tumor biological characteristics. RESULTS: Tumors with lymph node involvement showed a higher perfusion, whereas no significant differences in SUV_max or SUV_mean were reported. TN tumors had a higher metabolic activity than HER2 and luminal tumors but no significant differences in global BF values were noted. HER2 tumors exhibited a larger tumor heterogeneity of both perfusion and metabolism compared to luminal and TN tumors. Heterogeneity of perfusion appeared well correlated to that of metabolism. CONCLUSIONS: The study of breast cancer perfusion shows a higher BF in large tumors and in tumors with lymph node involvement, not paralleled by similar modifications in tumor global metabolism. In addition, the observed correlation between the perfusion heterogeneity and the metabolism heterogeneity suggests that tumor perfusion and consequently the process of tumor angiogenesis might be involved in the metabolism heterogeneity previously shown in BC.
PURPOSE: The aim of this prospective study is to analyze the global tumor blood flow (BF) and its heterogeneity in newly diagnosed breast cancer (BC) according to tumor biological characteristics and molecular subtypes. These perfusion parameters were compared to those classically derived from metabolic studies to investigate links between perfusion and metabolism. METHODS: Two hundred seventeen newly diagnosed BC patients underwent a 18F-FDG PET/CT exam before any treatment. A 2-min dynamic acquisition, centered on the chest, was performed immediately after intravenous injection of 3 MBq/kg of 18F-FDG, followed by a two-step static acquisition 90 min later. Tumor BF was calculated (in ml/min/g) using a single compartment kinetic model. In addition to standard PET parameters, texture features (TF) describing the heterogeneity of tumor perfusion and metabolism were extracted. Patients were divided into three groups: Luminal (HR+/HER2-), HER2 (HER2+), and TN (HR-/HER2-). Global and TF parameters of BF and metabolism were compared in different groups of patients according to tumor biological characteristics. RESULTS:Tumors with lymph node involvement showed a higher perfusion, whereas no significant differences in SUV_max or SUV_mean were reported. TN tumors had a higher metabolic activity than HER2 and luminal tumors but no significant differences in global BF values were noted. HER2 tumors exhibited a larger tumor heterogeneity of both perfusion and metabolism compared to luminal and TN tumors. Heterogeneity of perfusion appeared well correlated to that of metabolism. CONCLUSIONS: The study of breast cancer perfusion shows a higher BF in large tumors and in tumors with lymph node involvement, not paralleled by similar modifications in tumor global metabolism. In addition, the observed correlation between the perfusion heterogeneity and the metabolism heterogeneity suggests that tumor perfusion and consequently the process of tumor angiogenesis might be involved in the metabolism heterogeneity previously shown in BC.
Entities:
Keywords:
18F-FDG PET/CT; Blood flow; Breast cancer; Heterogeneity; Textural features
Authors: Jarle B Arnes; Ingunn M Stefansson; Oddbjørn Straume; Jan P Baak; Per E Lønning; William D Foulkes; Lars A Akslen Journal: Breast Cancer Res Treat Date: 2011-09-27 Impact factor: 4.872
Authors: Jennifer M Specht; Brenda F Kurland; Susan K Montgomery; Lisa K Dunnwald; Robert K Doot; Julie R Gralow; Georgina K Ellis; Hannah M Linden; Robert B Livingston; Kimberly H Allison; Erin K Schubert; David A Mankoff Journal: Clin Cancer Res Date: 2010-05-11 Impact factor: 12.531
Authors: M D Walker; M-C Asselin; P J Julyan; M Feldmann; P S Talbot; T Jones; J C Matthews Journal: Phys Med Biol Date: 2011-01-20 Impact factor: 3.609
Authors: Igor Maiborodin; Alfija Mansurova; Alexander Chernyavskiy; Alexander Romanov; Vladimir Voitcitctkii; Anna Kedrova; Alexander Tarkhov; Alena Chernyshova; Sergey Krasil'nikov Journal: J Pers Med Date: 2022-02-22